Legislative record

HB 1099STATE · South DakotaIntroduced

reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Voted 3/10/2026View source

Summary

No summary has been published for this bill yet.

Bill text

The full text of this bill isn't on Heard yet. The official documents are linked below.

Roll-call record

How representatives voted

98 yea·19 nay·8 other

Docket history

Action history

  1. 3/10/2026Signed by the Governor on 2026-03-10 H.J. 547
  2. 3/5/2026Delivered to the Governor on 2026-03-05 H.J. 520
  3. 3/4/2026Signed by the President S.J. 470
  4. 3/3/2026Signed by the Speaker H.J. 492
  5. 3/2/2026Senate Do Pass , Passed, YEAS 21, NAYS 12 S.J. 429
  6. 2/26/2026Remove from Consent Calendar S.J. 412
  7. 2/25/2026Scheduled for hearing S.J. 1
  8. 2/25/2026Health and Human Services Do Pass , Passed, YEAS 6, NAYS 0 S.J. 21
  9. 2/25/2026Certified uncontested, placed on consent , Passed, S.J. 21
  10. 2/10/2026First read in Senate and referred to Senate Health and Human Services S.J. 232